Latest Private Placement News

Mesoblast has raised A$260 million through a global private placement to fund the US commercial launch of its FDA-approved cell therapy Ryoncil® and accelerate clinical development in chronic low back pain.

DomaCom Limited has announced a $1.5 million placement to Lumiere Lifestyle Group, alongside the launch of three innovative funds targeting care and disability accommodation sectors, reinforcing its growth strategy and financial position.